Gladstone Institutional Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-664
| Closed | -$309K | – | 747 |
|
|
2024
Q3 | $309K | Sell |
664
-649
| -49% | -$302K | 0.02% | 569 |
|
|
2024
Q2 | $615K | Sell |
1,313
-2,437
| -65% | -$1.14M | 0.03% | 380 |
|
|
2024
Q1 | $1.57M | Sell |
3,750
-4,835
| -56% | -$2.02M | 0.09% | 247 |
|
|
2023
Q4 | $3.49M | Buy |
8,585
+1,484
| +21% | +$604K | 0.2% | 134 |
|
|
2023
Q3 | $2.47M | Buy |
7,101
+253
| +4% | +$88K | 0.16% | 164 |
|
|
2023
Q2 | $2.41M | Buy |
6,848
+231
| +3% | +$81.3K | 0.15% | 176 |
|
|
2023
Q1 | $2.08M | Sell |
6,617
-2,922
| -31% | -$921K | 0.14% | 187 |
|
|
2022
Q4 | $2.75M | Buy |
+9,539
| New | +$2.75M | 0.19% | 152 |
|